Dalfopristin/quinupristin Interactions
There are 344 drugs known to interact with dalfopristin/quinupristin, along with 2 disease interactions. Of the total drug interactions, 84 are major, 236 are moderate, and 24 are minor.
- View all 344 medications that may interact with dalfopristin/quinupristin
- View dalfopristin/quinupristin disease interactions (2)
Most frequently checked interactions
View interaction reports for dalfopristin / quinupristin and the medicines listed below.
- Adcetris (brentuximab)
- Adcetris (brentuximab)
- Adriamycin RDF (doxorubicin)
- Adriamycin RDF (doxorubicin)
- Alprolix (coagulation factor ix)
- Alprolix (coagulation factor ix)
- Baraclude (entecavir)
- Baraclude (entecavir)
- Bebulin VH (factor ix complex)
- Bebulin VH (factor ix complex)
- BeneFix (coagulation factor ix)
- BeneFix (coagulation factor ix)
- Besponsa (inotuzumab ozogamicin)
- Besponsa (inotuzumab ozogamicin)
- Biaxin (clarithromycin)
- Biaxin (clarithromycin)
- Blincyto (blinatumomab)
- Blincyto (blinatumomab)
- CellCept (mycophenolate mofetil)
- CellCept (mycophenolate mofetil)
- Cimzia (certolizumab)
- Cimzia (certolizumab)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coagadex (coagulation factor x)
- Coagadex (coagulation factor x)
- Corlanor (ivabradine)
- Corlanor (ivabradine)
- Demerol (meperidine)
- Demerol (meperidine)
Dalfopristin/quinupristin disease interactions
There are 2 disease interactions with dalfopristin / quinupristin which include:
More about dalfopristin / quinupristin
- dalfopristin/quinupristin consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: streptogramins
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.